Suppr超能文献

刚地弓形虫分泌效应物劫持宿主抑制物复合物抑制细胞坏死性凋亡。

Toxoplasma gondii secreted effectors co-opt host repressor complexes to inhibit necroptosis.

机构信息

Department of Molecular Microbiology, Washington University School of Medicine in St. Louis, St. Louis, MO 63130, USA.

Department of Molecular Microbiology, Washington University School of Medicine in St. Louis, St. Louis, MO 63130, USA.

出版信息

Cell Host Microbe. 2021 Jul 14;29(7):1186-1198.e8. doi: 10.1016/j.chom.2021.04.016. Epub 2021 May 26.

Abstract

Toxoplasma gondii translocates effector proteins into its host cell to subvert various host pathways. T. gondii effector TgIST blocks the transcription of interferon-stimulated genes to reduce immune defense. Interferons upregulate numerous genes, including protein kinase R (PKR), which induce necrosome formation to activate mixed-lineage-kinase-domain-like (MLKL) pseudokinase and induce necroptosis. Whether these interferon functions are targeted by Toxoplasma is unknown. Here, we examine secreted effectors that localize to the host cell nucleus and find that the chronic bradyzoite stage secretes effector TgNSM that targets the NCoR/SMRT complex, a repressor for various transcription factors, to inhibit interferon-regulated genes involved in cell death. TgNSM acts with TgIST to block IFN-driven expression of PKR and MLKL, thus preventing host cell necroptotic death and protecting the parasite's intracellular niche. The mechanism of action of TgNSM uncovers a role of NCoR/SMRT in necroptosis, assuring survival of intracellular cysts and chronic infection.

摘要

刚地弓形虫将效应蛋白转运到宿主细胞中,以颠覆各种宿主途径。刚地弓形虫效应蛋白 TgIST 阻断干扰素刺激基因的转录,以降低免疫防御。干扰素上调许多基因,包括蛋白激酶 R(PKR),其诱导坏死小体形成以激活混合谱系激酶结构域样(MLKL)假激酶并诱导细胞坏死性凋亡。弓形虫是否靶向这些干扰素功能尚不清楚。在这里,我们检查了定位于宿主细胞核的分泌效应物,发现慢性缓殖子阶段分泌的效应蛋白 TgNSM 靶向 NCoR/SMRT 复合物,该复合物是各种转录因子的抑制剂,以抑制与细胞死亡相关的干扰素调节基因。TgNSM 与 TgIST 一起作用以阻断 IFN 驱动的 PKR 和 MLKL 的表达,从而防止宿主细胞坏死性死亡并保护寄生虫的细胞内小生境。TgNSM 的作用机制揭示了 NCoR/SMRT 在坏死性凋亡中的作用,确保了细胞内包囊和慢性感染的存活。

相似文献

1
Toxoplasma gondii secreted effectors co-opt host repressor complexes to inhibit necroptosis.
Cell Host Microbe. 2021 Jul 14;29(7):1186-1198.e8. doi: 10.1016/j.chom.2021.04.016. Epub 2021 May 26.
2
A combination of four nuclear-targeted effectors protects against interferon gamma-driven human host cell death.
mBio. 2024 Oct 16;15(10):e0212424. doi: 10.1128/mbio.02124-24. Epub 2024 Sep 18.
3
RIPK3 Facilitates Host Resistance to Oral Toxoplasma gondii Infection.
Infect Immun. 2021 Apr 16;89(5). doi: 10.1128/IAI.00021-21.
5
Toxoplasma gondii Is Required for Placenta-Specific Induction of the Regulatory Chemokine CCL22 in Human and Mouse.
mBio. 2021 Dec 21;12(6):e0159121. doi: 10.1128/mBio.01591-21. Epub 2021 Nov 16.
7
Characterization of Protein Effector Export in the Bradyzoite Stage of Toxoplasma gondii.
mBio. 2020 Mar 10;11(2):e00046-20. doi: 10.1128/mBio.00046-20.
8
Epigenetic Modifiers Alter Host Cell Transcription to Promote Toxoplasma Infection.
ACS Infect Dis. 2022 Mar 11;8(3):411-413. doi: 10.1021/acsinfecdis.2c00054. Epub 2022 Feb 24.
10

引用本文的文献

1
Next-Generation Protein-Ligand Interaction Networks: APEX as a Powerful Technology.
Proteomes. 2025 Jun 23;13(3):26. doi: 10.3390/proteomes13030026.
2
Necroptosis in vascular cognitive impairment: mechanisms and therapeutic potential.
Front Aging Neurosci. 2025 Jun 25;17:1599773. doi: 10.3389/fnagi.2025.1599773. eCollection 2025.
4
chitinase-like protein orchestrates cyst wall glycosylation to facilitate effector export and cyst turnover.
Proc Natl Acad Sci U S A. 2025 Feb 4;122(5):e2416870122. doi: 10.1073/pnas.2416870122. Epub 2025 Jan 29.
5
6
Pathological mechanisms of glial cell activation and neurodegenerative and neuropsychiatric disorders caused by infection.
Front Microbiol. 2024 Dec 11;15:1512233. doi: 10.3389/fmicb.2024.1512233. eCollection 2024.
7
8
ROP5 Enhances Type I IFN Responses by Promoting Ubiquitination of STING.
Int J Mol Sci. 2024 Oct 19;25(20):11262. doi: 10.3390/ijms252011262.
9
Engineering Toxoplasma gondii secretion systems for intracellular delivery of multiple large therapeutic proteins to neurons.
Nat Microbiol. 2024 Aug;9(8):2051-2072. doi: 10.1038/s41564-024-01750-6. Epub 2024 Jul 29.
10
Mutual regulations between and type I interferon.
Front Immunol. 2024 Jul 8;15:1428232. doi: 10.3389/fimmu.2024.1428232. eCollection 2024.

本文引用的文献

1
Transcriptional modification of host cells harboring Toxoplasma gondii bradyzoites prevents IFN gamma-mediated cell death.
Cell Host Microbe. 2022 Feb 9;30(2):232-247.e6. doi: 10.1016/j.chom.2021.11.012. Epub 2021 Dec 17.
2
RIPK3 Facilitates Host Resistance to Oral Toxoplasma gondii Infection.
Infect Immun. 2021 Apr 16;89(5). doi: 10.1128/IAI.00021-21.
3
Mechanisms for Delivery of Proteins and Uptake of Nutrients Across the Host-Pathogen Interface.
Annu Rev Microbiol. 2020 Sep 8;74:567-586. doi: 10.1146/annurev-micro-011720-122318. Epub 2020 Jul 17.
4
Characterization of Protein Effector Export in the Bradyzoite Stage of Toxoplasma gondii.
mBio. 2020 Mar 10;11(2):e00046-20. doi: 10.1128/mBio.00046-20.
5
The reactome pathway knowledgebase.
Nucleic Acids Res. 2020 Jan 8;48(D1):D498-D503. doi: 10.1093/nar/gkz1031.
6
Translocation of effector proteins into host cells by Toxoplasma gondii.
Curr Opin Microbiol. 2019 Dec;52:130-138. doi: 10.1016/j.mib.2019.07.002. Epub 2019 Aug 23.
7
effector TgIST blocks type I interferon signaling to promote infection.
Proc Natl Acad Sci U S A. 2019 Aug 27;116(35):17480-17491. doi: 10.1073/pnas.1904637116. Epub 2019 Aug 14.
8
Caspase-8 promotes c-Rel-dependent inflammatory cytokine expression and resistance against .
Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11926-11935. doi: 10.1073/pnas.1820529116. Epub 2019 May 30.
10
The Toxoplasma effector TEEGR promotes parasite persistence by modulating NF-κB signalling via EZH2.
Nat Microbiol. 2019 Jul;4(7):1208-1220. doi: 10.1038/s41564-019-0431-8. Epub 2019 Apr 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验